Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
OMX Stockholm Telecommunications PI | SX15PI | 6. nov 2024 | 842.71 | -1.13 |
OMX Stockholm Travel & Leisure PI | SX4050PI | 6. nov 2024 | 7 297.94 | -1.07 |
OMX Stockholm Utilities PI | SX65PI | 6. nov 2024 | 489.82 | +0.17 |
OMXS SC 30 ESG Responsible GI | OMXSS30ESGGI | 6. nov 2024 | 891.96 | -1.59 |
Oncopeptides | ONCO | 6. nov 2024 | 2.08 | -0.24 |
OncoZenge | ONCOZ | 6. nov 2024 | 8.89 | -3.47 |
Oneflow | ONEF | 6. nov 2024 | 34.00 | -0.87 |
Online Brands Nordic | OBAB | 6. nov 2024 | 10.45 | +0.48 |
oodash Group | OODA | 6. nov 2024 | 38.20 | -12.18 |
Opter | OPTER | 6. nov 2024 | 118.00 | -1.26 |
OptiCept Technologies | OPTI | 6. nov 2024 | 5.03 | -1.57 |
Orexo | ORX | 6. nov 2024 | 11.00 | +0.92 |
OrganoClick | ORGC | 6. nov 2024 | 2.90 | -3.33 |
Orron Energy AB | ORRON | 6. nov 2024 | 7.02 | -0.57 |
Ortivus A | ORTIA | 6. nov 2024 | 2.98 | +2.05 |
Ortivus B | ORTIB | 6. nov 2024 | 1.60 | +0.31 |
Ortoma B | ORTB | 6. nov 2024 | 8.60 | +0.94 |
Oscar Properties Holding Pref | OPPREF | 6. nov 2024 | 85.50 | 0.00 |
Oscar Properties Holding Pref B | OPPREFB | 6. nov 2024 | 855.00 | 0.00 |
OssDsign | OSSD | 6. nov 2024 | 6.24 | -3.41 |
OurLiving AB | OURLIV | 6. nov 2024 | 0.22 | +0.91 |
Ovzon | OVZON | 6. nov 2024 | 10.66 | -9.20 |
OXE Marine | OXE | 6. nov 2024 | 0.39 | +1.57 |
Pandox B | PNDXB | 6. nov 2024 | 181.40 | -3.30 |
Paradox Interactive | PDX | 6. nov 2024 | 195.00 | +0.67 |
Paxman | PAX | 6. nov 2024 | 69.00 | -0.29 |
Peab B | PEABB | 6. nov 2024 | 83.40 | -0.24 |
Peptonic Medical | PMED | 6. nov 2024 | 0.01 | -25.71 |
Perpetua Medical B | PERPB | 6. nov 2024 | 4.54 | +3.78 |
PetroNor E&P ASA | PNORO | 6. nov 2024 | 9.70 | -1.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.